Issue Date
--
Investment/lot
--
Price Range
--
Lot Size
--
IPO Size
N/A
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
The IPO of Anondita Medicare Ltd comprises a fresh issue of up to 47,93,000 equity shares of face value of ₹10 each. There is no offer for sale in this 100% book-built issue.
Investor | Shares Offered |
---|---|
QIBs | Not more than 50% of the offer |
Non-institutional Investor | Not less than 15% of the offer |
Retail Individual Investors | Not less than 35% of the offer |
The Indian condom market holds a crucial position within the global contraceptive market. As of 2022, the market was valued at approximately USD 200 million. It has been experiencing robust growth, with a valuation of around USD 214 million in 2023.
Future projections suggest a promising outlook, with the market anticipated to reach USD 355 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030.
Anondita Medicare Ltd is a manufacturer of male condoms with a variety of flavors, with its flagship product marketed and sold under the brand ‘COBRA’. It has an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
The strengths of Anondita Medicare IPO and the basis of its issue price are
Dependence on Top 10 Customers: The company depends on its top 10 customers for a significant portion of its revenues. The loss of a major customer or significant reduction in demand from any of its major customers may adversely affect its business, financial condition, results of operations and prospects.
Geographical Concentration: The company’s business operations span various regions across India and extend beyond international borders. Despite its diversified presence, it has a significant dependency on Delhi, Uttar Pradesh and Haryana, which contributed (100%, 91.86%, 94.36%, and 74.03%) of its total revenue from operations for the period ended on 30th June 2024, and for the financial years ending on March 31, 2024, March 31, 2023 and March 31, 2022, respectively.
Any factors relating to political and geographical changes in these states, growing competition and any change in demand may adversely affect its business.
Particulars (in Rs. crores)
Particulars (in Rs. crores)
Company Name | PAT (in ₹ crores) | Return on Net Worth (in %) | NAV (in ₹ per share) |
---|---|---|---|
Anondita Medicare Ltd | 2.16 | 12.45 | 20.57 |
Cupid Ltd | 8.25 | NA | NA |
Business Model
Manufacturer of male condoms under the brand ‘Cobra’, Anondita Medicare Ltd’s condoms are available under different flavours such as strawberry, mint, chocolate, butterscotch, coffee, bubblegum, etc. Encouraged by demand and overwhelming responses from consumers it has also started the production of female condoms.
Company Growth Trajectory
The company’s revenue from operations grew from ₹23.0993 crores in FY 22 to ₹46.4321 crores in FY 24. The EBITDA margin grew from 18.12% in FY 22 to 19.58% in FY 24, while PAT increased from ₹1.5840 crores in FY 22 to ₹3.8447 crores in FY 24. Quality assurance and control coupled with cordial relations with customers has helped the company grow with time.
Market Position
Incorporated in March 2024, Anondita Medicare Ltd boasts a state-of-the-art plant located in Noida, Uttar Pradesh. Its manufacturing capability is supported by 11 existing manufacturing lines at the moment.
Parameter | FY 24 | FY 23 | FY 22 |
---|---|---|---|
Total Revenue (in ₹ crores) | 46.55 | 36.13 | 23.25 |
Profit Before Tax (in ₹ crores) | 5.15 | 0.46 | 2.19 |
Profit After Tax (in ₹ crores) | 3.84 | 0.34 | 1.58 |
EPS in ₹ | NA | NA | NA |
Parameter | FY 24 | FY 23 | FY 22 |
---|---|---|---|
Profit Before Tax (in ₹ crores) | 5.15 | 0.46 | 2.19 |
Net Cash Provided / (used) by Operating Activities (in ₹ crores) | 7.75 | (9.16) | 4.03 |
Net Cash Provided / (used) by Investing Activities (in ₹ crores) | (3.74) | (0.58) | (1.00) |
Net Cash Provided / (used) by Financing Activities (in ₹ crores) | (3.99) | 9.90 | (3.16) |
Cash and Cash Equivalents at the End of Period (in ₹ crores) | 0.26 | 0.25 | 0.10 |
Via the Registrar’s Website
Check on the National Stock Exchange Website
The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Anondita Medicare Ltd. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.
On the NSE IPO Bid Verification page, enter:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
You can read more about Anondita Medicare and its IPO from the company’s red herring prospectus (RHP) here.
The IPO of Anondita Medicare Ltd comprises a fresh issue of up to 47,93,000 equity shares
The exact dates of the IPO are yet to be announced.